Related Experiment Videos
Lichen sclerosus
1Elizabeth Garrett Anderson Hospital, London, England.
Dermatologic Clinics
|April 1, 1992
Summary
Lichen sclerosus is a recognized autoimmune skin condition affecting all ages and sexes. Current management focuses on emollients and topical corticosteroids, with a recognized risk of malignancy requiring ongoing patient review.
Area of Science:
- Dermatology
- Pathology
- Gynecology
Background:
- Lichen sclerosus is a distinct clinical and histologic skin entity.
- Its etiology and pathogenesis remain unestablished, but an association with autoimmune diseases is recognized.
- Historically, its anogenital predilection in women created diagnostic and management confusion between specialties.
Purpose of the Study:
- To clarify the classification of lichen sclerosus.
- To outline current, evidence-based management strategies.
- To emphasize the importance of long-term follow-up due to malignancy risk.
Main Methods:
- Review of existing literature and clinical consensus.
- Formulation of a unified classification system by international societies (ISSVD and ISGyP).
Main Results:
- A new classification acceptable to gynecologists, dermatologists, and pathologists has been established.
- Current management emphasizes emollients and topical corticosteroids, moving away from surgical interventions like vulvectomy for benign cases.
- The risk of malignancy in lichen sclerosus is confirmed, though currently unquantifiable.
Conclusions:
- The unified classification aims to standardize diagnosis and management.
- Logical management strategies now prioritize conservative treatments.
- Vigilant patient monitoring is crucial due to the potential for malignant transformation.